The Present and Future Use of β-Blockers
- 7 Downloads
The current state of knowledge about β-blockers in treating hypertension and their comparative pharmacology is reviewed. Some new developments in antihypertensive therapy, such as converting-enzyme inhibitors and calcium antagonistic drugs are discussed and their place vis-a-vis the β-blockers analysed.
KeywordsCaptopril Atenolol Calcium Antagonist Oxprenolol Lipid Solubility
Unable to display preview. Download preview PDF.
- Barbarino, A. and De Marinis, L.: Calcium antagonists and hormone release. II. Effects of verapamil on basal, gonadotropin-releasing hormone and thyrotropin-releasing hormone-induced pituitary hormone release in normal subjects. Journal of Clinical Endocrinology and Metabolism 51: 749–754 (1980).PubMedCrossRefGoogle Scholar
- Bühler, F.R.; Burkhart, F.; Lutold, B.E.; Kung, M.; Marbet, G. and Pfisterer, M.: Antihypertensive beta-blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. American Journal of Cardiology 35: 653–669 (1975).CrossRefGoogle Scholar
- Kaplan, N.M.: Clinical Hypertension (3rd ed.) pp. 98–192 (Williams and Wilkins, Baltimore 1982).Google Scholar
- Rubin, R.P.: Actions of calcium antagonists of secretory cells: in Weiss, G.B. (Ed.) New Perspectives on Calcium Antagonists, pp. 147–158 (American Physiology Society, Bethesda, Maryland 1981).Google Scholar